The CNBX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CNBX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CNBX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CNBX Detailed Price Forecast - CNN Money||View CNBX Detailed Summary - Google Finance|
|View CNBX Detailed Summary - Yahoo! Finance||View CNBX Stock Research & Analysis - Zacks.com|
|View CNBX Trends & Analysis - Trade-Ideas||View CNBX Major Holders - Barrons|
|View CNBX Call Transcripts - NASDAQ||View CNBX Breaking News & Analysis - Seeking Alpha|
|View CNBX Annual Report - CompanySpotlight.com||View CNBX OTC Short Report - OTCShortReport.com|
|View CNBX Fundamentals - TradeKing||View CNBX SEC Filings - Bar Chart|
|View Historical Prices for CNBX - The WSJ||View Performance/Total Return for CNBX - Morningstar|
|View the Analyst Estimates for CNBX - MarketWatch||View the Earnings History for CNBX - CNBC|
|View the CNBX Earnings - StockMarketWatch||View CNBX Buy or Sell Recommendations - MacroAxis|
|View the CNBX Bullish Patterns - American Bulls||View CNBX Short Pain Metrics - ShortPainBot.com|
|View CNBX Stock Mentions - StockTwits||View CNBX Stock Mentions - PennyStockTweets|
|View CNBX Stock Mentions - Twitter||View CNBX Investment Forum News - Investor Hub|
|View CNBX Stock Mentions - Yahoo! Message Board||View CNBX Stock Mentions - Seeking Alpha|
|View Insider Transactions for CNBX - SECform4.com||View Insider Transactions for CNBX - Insider Cow|
|View CNBX Major Holdings Summary - CNBC||View Insider Disclosure for CNBX - OTC Markets|
|View Insider Transactions for CNBX - Yahoo! Finance||View Institutional Holdings for CNBX - NASDAQ|
|View CNBX Stock Insight & Charts - FinViz.com||View CNBX Investment Charts - StockCharts.com|
|View CNBX Stock Overview & Charts - BarChart||View CNBX User Generated Charts - Trading View|
TEL AVIV, Israel and BETHESDA, Maryland, April 17, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has obtained approval for a nationwide Israeli multisite clinical study on the antitumor properties of cannabinoid compounds on primary cancer biopsies. The apoptotic/cytotoxic effects of a multitude of cannabinoid extracts will be evaluated via Cannabics' high throughput screening platform. Dr. Eyal Ballan, CTO and Co-Founder of Cannabics, said: "We believe this is a quantum leap for the research on the biology of cancer and cannabinoids.
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
Posted on Wednesday March 13, 2019
OTCQX and OTCQB Companies Featured at 2019 ROTH Conference NEW YORK , March 13, 2019 /PRNewswire/ -- OTC Markets Group Inc . (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, ...
SodaStream CEO Daniel Birnbaum to Join Seedo Board
Posted on Tuesday March 12, 2019
Seedo Corp. is an agro-tech company providing the world's first fully automated and controlled indoor growing machine for pesticide-free agricultural and vertical farming markets. Cannabics owns approximately 20% of Seedo Corp.'s issued and outstanding common stock.
Cannabics Pharmaceuticals Closes Agreement With Wize Pharma
Posted on Wednesday March 06, 2019
BETHESDA, Maryland and TEL AVIV, Israel, March 6, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) a world leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has closed an agreement with Wize Pharma, Inc. (WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, and that has distribution rights of known medical formulae related to eye diseases, to form a equally owned joint venture (JV) which will focus on the research and development of cannabinoid based treatments for ophthalmic disorders.